Official SEC submissions

Processa Pharmaceuticals SEC Filings

Direct answer

Processa Pharmaceuticals's latest SEC filing is DEFA14A.

It was filed on November 5, 2026, and 40 recent filings are available.
Each row links directly to the SEC document and filing index.
Official SEC EDGAR submissions

Get free Processa Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

DEFA14A

Proxy statement

Filed:

DEFA14A

Open SEC documentView filing index

DEFA14A

Proxy statement

Filed:

DEFA14A

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

DEF 14A

Proxy statement

Filed:

Report date:

DEF 14A

Open SEC documentView filing index

8-K/A

Current report

Filed:

Report date:

8-K/A

Open SEC documentView filing index

10-Q

Periodic report

Filed:

Report date:

10-Q

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

DEF 14A

Proxy statement

Filed:

Report date:

DEF 14A

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

Verified data

Recent filing categories
4
Recent filings
40
SEC CIK
0001533743
Latest filing date
November 5, 2026

Explore related company data

View the Processa Pharmaceuticals company profileView Processa Pharmaceuticals annual financials